Endocrine Surgery Practice Questions

Q: A patient presents with perioral paresthesia following thyroid surgery. Serum calcium levels are 7 mg/dL. What is the most appropriate management?

Oral calcium. **Explanation:** The patient is presenting with **symptomatic hypocalcemia** (perioral paresthesia) following thyroid surgery, a common complication due to transient ischemia or accidental removal of the parathyroid glands. **1. Why Oral Calcium is correct:** The management of post-thyroidectomy hypocalcemia depends on the severity of symptoms and the absolute calcium level. In patients with **mild symptoms** (like isolated perioral paresthesia) and a serum calcium level above 6.5–7.0 mg/dL, **oral calcium supplementation** is the first-line treatment. It is effective, safer than IV administration, and sufficient to alleviate mild neuromuscular irritability. **2. Why other options are incorrect:** * **IV Calcium Gluconate:** This is reserved for **emergency management** of severe hypocalcemia (e.g., tetany, carpopedal spasm, seizures, or QTc prolongation). While the patient is symptomatic, perioral paresthesia alone does not necessitate the risks associated with rapid IV calcium infusion unless oral therapy fails or symptoms progress. * **Oral Vitamin D3 (with or without Calcium):** Vitamin D3 (Cholecalciferol) requires hepatic and renal hydroxylation and has a slow onset of action. In acute post-surgical hypoparathyroidism, **Calcitriol** (active Vitamin D) is preferred over D3 if oral calcium alone is insufficient. **NEET-PG High-Yield Pearls:** * **Most common cause** of post-thyroidectomy hypocalcemia: Devitalization of parathyroid glands. * **Chvostek’s sign:** Tapping the facial nerve leads to facial twitching. * **Trousseau’s sign:** Carpal spasm induced by inflating a BP cuff (more sensitive than Chvostek). * **ECG finding:** Prolonged QT interval. * **Hungry Bone Syndrome:** Severe, prolonged hypocalcemia seen after surgery for hyperparathyroidism (not thyroidectomy).

Q: What is considered the gold standard for diagnosing pheochromocytoma?

Biopsy. In the context of medical diagnostics, the **"Gold Standard"** refers to the definitive test that provides the absolute confirmation of a disease. For **Pheochromocytoma**, while biochemical and imaging tests are used for screening and localization, the definitive diagnosis is always **Histopathology (Biopsy/Excision)**. ### Why Biopsy is the Gold Standard: Pheochromocytoma is a catecholamine-secreting tumor of the adrenal medulla. The definitive confirmation requires microscopic examination to identify characteristic features like the **"Zellballen" pattern** (nested clusters of chromaffin cells). However, it is critical to note that in clinical practice, a biopsy is **never** performed before biochemical stabilization and surgical excision due to the risk of a life-threatening hypertensive crisis. ### Why Other Options are Incorrect: * **Urinary/Plasma Metanephrines:** These are the **best initial screening tests** due to their high sensitivity. While they suggest the diagnosis, they are not "gold standard" confirmatory tests. * **CT Abdomen:** This is the **investigation of choice for localization** once the diagnosis is biochemically established. It cannot differentiate between a pheochromocytoma and other adrenal masses (like adenomas) with 100% certainty. * **MIBG Scan:** This is a functional imaging modality used primarily to detect **extra-adrenal (paragangliomas)** or metastatic disease. ### High-Yield Clinical Pearls for NEET-PG: * **Rule of 10s:** 10% are bilateral, 10% are malignant, 10% are extra-adrenal, and 10% are familial. * **Pre-op Management:** Always give **Alpha-blockers first** (e.g., Phenoxybenzamine) followed by Beta-blockers to prevent a hypertensive crisis. * **Histology:** Look for the **Zellballen pattern** and **Chromogranin A** positivity. * **Malignancy:** The only absolute criterion for malignancy in pheochromocytoma is the **presence of distant metastasis** (not local invasion or cellular atypia).

Q: Lymphatic spread is most commonly seen in which type of thyroid malignancy?

Papillary carcinoma. **Explanation:** The correct answer is **Papillary Carcinoma (Option A)**. **Why Papillary Carcinoma is correct:** Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Its hallmark characteristic is a strong predilection for **lymphatic spread**. Approximately 30–80% of patients have cervical lymph node involvement at the time of diagnosis. This occurs via the intrathyroidal lymphatic network, typically involving the central compartment (Level VI) first, followed by the lateral neck nodes. **Why the other options are incorrect:** * **Follicular Carcinoma (Option B):** This tumor characteristically spreads via the **hematogenous (bloodborne) route** rather than lymphatics. This is because follicular cells tend to invade thin-walled blood vessels, leading to distant metastases in the bones and lungs. * **Medullary Carcinoma (Option C):** While medullary carcinoma frequently involves lymph nodes (early and aggressively), it is less common overall than Papillary carcinoma. In the context of "most common thyroid malignancy with lymphatic spread," Papillary remains the definitive answer. * **Anaplastic Carcinoma (Option D):** This is a highly aggressive, undifferentiated tumor. While it spreads via both lymphatics and blood, its primary clinical feature is rapid **local invasion** of surrounding structures (trachea, esophagus, nerves) rather than isolated lymphatic spread. **High-Yield Clinical Pearls for NEET-PG:** * **Psammoma bodies:** Laminated calcifications seen on histology in Papillary carcinoma (Pathognomonic). * **Orphan Annie Eye nuclei:** Clear, ground-glass nuclei seen in Papillary carcinoma. * **Prognosis:** Papillary has the best prognosis, while Anaplastic has the worst. * **Route of Spread Mnemonic:** **P**apillary = **P**alpable Nodes (Lymphatic); **F**ollicular = **F**ar-away organs (Hematogenous).

Q: What is the treatment for localized and well-differentiated carcinoma of the thyroid?

Near total thyroidectomy, radioisotope. **Explanation:** The management of well-differentiated thyroid carcinoma (WDTC), which includes **Papillary** and **Follicular** thyroid cancers, is centered on surgical clearance followed by adjuvant therapy to eliminate microscopic residual disease. **1. Why Option A is Correct:** For localized WDTC, the standard of care is **Near-total thyroidectomy (NTT)** or **Total thyroidectomy (TT)**. NTT involves removing all visible thyroid tissue except for a small amount (<1 gram) near the recurrent laryngeal nerve or parathyroid glands to prevent injury. Following surgery, **Radioactive Iodine (RAI/Radioisotope - I-131)** is administered. RAI serves two purposes: it ablates any remaining thyroid remnant and acts as a diagnostic tool to detect and treat distant metastases. **2. Why Other Options are Incorrect:** * **Option B:** Subtotal thyroidectomy is inadequate for malignancy as it leaves too much tissue behind, making RAI ablation ineffective and increasing recurrence risk. **External Beam Radiation (EBRT)** is not a primary treatment for WDTC; it is reserved for palliative care or unresectable anaplastic cases. * **Option C & D:** These include EBRT. WDTC is highly **radioresistant** to external radiation but **radiosensitive** to internal radioisotopes (I-131). Therefore, EBRT is not part of the standard protocol for localized, well-differentiated disease. **Clinical Pearls for NEET-PG:** * **Thyroglobulin (Tg):** Used as a tumor marker for follow-up *after* total thyroidectomy and ablation. * **McHenry’s Rule:** If the nodule is >1 cm, TT/NTT is preferred; if <1 cm (microcarcinoma) and low risk, hemithyroidectomy may be considered. * **Levothyroxine:** Post-operatively, patients require lifelong TSH suppression therapy (keeping TSH <0.1 mU/L) to prevent stimulation of any dormant cancer cells.

Q: What is the most common site of ectopic pheochromocytoma?

Organ of Zuckerkandl. **Explanation:** Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells. While 90% occur in the adrenal medulla, 10% are extra-adrenal, referred to as **paragangliomas**. **1. Why Organ of Zuckerkandl is correct:** The **Organ of Zuckerkandl** is a collection of chromaffin tissue located at the origin of the **inferior mesenteric artery** (near the aortic bifurcation). It is the largest collection of extra-adrenal chromaffin tissue in the body and is the **most common site** for ectopic (extra-adrenal) pheochromocytomas, accounting for approximately 50–75% of such cases. **2. Analysis of Incorrect Options:** * **Bladder:** While the urinary bladder is a well-known site for paragangliomas (often presenting with micturition-induced syncope or palpitations), it is less common than the Organ of Zuckerkandl. * **Filum terminale & Celiac plexus:** These are recognized but rare sites for paragangliomas. The celiac plexus is the second most common abdominal site, but still lags significantly behind the Organ of Zuckerkandl. **3. Clinical Pearls for NEET-PG:** * **The Rule of 10s:** Traditionally, Pheochromocytoma is 10% bilateral, 10% malignant, 10% pediatric, and **10% extra-adrenal**. (Note: Modern genetics suggest up to 30-35% may be hereditary). * **Malignancy Risk:** Extra-adrenal tumors (paragangliomas) have a **higher risk of malignancy** compared to adrenal pheochromocytomas. * **Diagnosis:** Best initial screening test is **24-hour urinary fractionated metanephrines** or plasma free metanephrines. * **Localization:** **MIBG scan** (123I-MIBG) is highly specific for locating ectopic or metastatic sites.

Q: What is true about follicular carcinoma of the thyroid?

More common in endemic areas. **Explanation:** Follicular Thyroid Carcinoma (FTC) is the second most common thyroid malignancy. Understanding its distinct pathological and epidemiological features is crucial for NEET-PG. **1. Why Option A is Correct:** FTC is significantly **more common in iodine-deficient (endemic) areas**. While Papillary carcinoma is the most common thyroid cancer overall, its relative incidence decreases in endemic regions, where FTC can account for up to 25-40% of cases. Chronic TSH stimulation due to low iodine is thought to contribute to its pathogenesis. **2. Why the other options are Incorrect:** * **Option B:** FTC is typically **encapsulated**. Unlike Papillary carcinoma, which is often unencapsulated and multifocal, FTC usually presents as a solitary, well-circumscribed, and encapsulated mass. * **Option C:** The mean age of presentation is usually **50 years** (the 5th decade). It typically presents about 10 years later than Papillary carcinoma (which peaks at 30–40 years). * **Option D:** This is a classic trap. Histopathology **cannot** easily differentiate FTC from a follicular adenoma based on cellular features alone. The diagnosis of malignancy requires the demonstration of **capsular invasion** or **vascular invasion**, which necessitates a formal histopathological examination of the entire capsule. Therefore, **FNAC cannot distinguish between the two.** **Clinical Pearls for NEET-PG:** * **Spread:** FTC spreads primarily via the **hematogenous route** (to lungs and bone), unlike Papillary carcinoma which spreads via lymphatics. * **Diagnosis:** "Follicular neoplasm" on FNAC is an indication for diagnostic lobectomy because cytology cannot assess capsular integrity. * **Hürthle Cell Carcinoma:** A variant of FTC characterized by oxyphilic cells; it is more aggressive and less likely to take up radioactive iodine. * **Molecular Marker:** Often associated with **RAS mutations** or **PAX8-PPARγ rearrangements**.

Q: A 40-year-old female presents with a slow-growing, painless mass. She is recently diagnosed with thyroid cancer. Which is the most common subtype of thyroid cancer?

Papillary carcinoma. **Explanation:** **Papillary Thyroid Carcinoma (PTC)** is the most common subtype of thyroid cancer, accounting for approximately **80–85%** of all thyroid malignancies. It typically presents as a slow-growing, painless, "cold" nodule in females (3rd–5th decades). The diagnosis is primarily made via Fine Needle Aspiration Cytology (FNAC), which reveals characteristic nuclear features like **Orphan Annie eye nuclei** (cleared-out chromatin), **Psammoma bodies** (laminated calcifications), and nuclear grooves. **Analysis of Incorrect Options:** * **Follicular Carcinoma (Option C):** The second most common (10–15%). Unlike PTC, it spreads **hematogenously** (to bone/lungs) and cannot be diagnosed by FNAC alone, as it requires histological evidence of capsular or vascular invasion. * **Medullary Carcinoma (Option A):** Accounts for ~5%. It arises from **Parafollicular C-cells** and secretes calcitonin. It is associated with MEN 2A and 2B syndromes. * **Anaplastic Carcinoma (Option D):** Rare (<2%) but highly aggressive. It typically presents in elderly patients as a rapidly enlarging mass with a very poor prognosis. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Spread:** PTC spreads primarily via **lymphatics** (Level VI nodes first). * **Risk Factor:** Prior exposure to **ionizing radiation** is the most significant risk factor for PTC. * **Prognosis:** PTC has an excellent 10-year survival rate (>90%). * **Molecular Marker:** **BRAF V600E** mutation is the most common genetic alteration in PTC.

Question 1

A patient presents with perioral paresthesia following thyroid surgery. Serum calcium levels are 7 mg/dL. What is the most appropriate management?

Accepted Answer

Oral calcium

Answer

Oral vitamin D3

Answer

Oral vitamin D3 with calcium

Answer

IV calcium gluconate

Question 2

A 40-year-old male presents with papillary thyroid cancer confined to one lobe of the thyroid, measuring 3x3 cm, with no palpable nodes. What is the ideal treatment?

Accepted Answer

Total thyroidectomy

Answer

Hemithyroidectomy

Answer

Subtotal Thyroidectomy

Answer

Total thyroidectomy with nodal dissection

Question 3

What is considered the gold standard for diagnosing pheochromocytoma?

Accepted Answer

Biopsy

Answer

Urinary metanephrines

Answer

CT Abdomen

Answer

MIBG scan

Question 4

Lymphatic spread is most commonly seen in which type of thyroid malignancy?

Accepted Answer

Papillary carcinoma

Answer

Follicular carcinoma

Answer

Medullary carcinoma

Answer

Anaplastic carcinoma

Question 5

What is the treatment for localized and well-differentiated carcinoma of the thyroid?

Accepted Answer

Near total thyroidectomy, radioisotope

Answer

Subtotal thyroidectomy with external beam irradiation

Answer

Near total thyroidectomy, iodine, external beam irradiation

Answer

Total thyroidectomy, external beam radiation, lifelong levothyroxine

Question 6

What is the most common site of ectopic pheochromocytoma?

Accepted Answer

Organ of Zuckerkandl

Answer

Bladder

Answer

Filum terminale

Answer

Celiac plexus

Question 7

What is true about follicular carcinoma of the thyroid?

Accepted Answer

More common in endemic areas

Answer

Non-encapsulated

Answer

Mean age of presentation is 40 years

Answer

Histopathology easily differentiates it from an adenoma

Question 8

A 40-year-old female presents with a slow-growing, painless mass. She is recently diagnosed with thyroid cancer. Which is the most common subtype of thyroid cancer?

Accepted Answer

Papillary carcinoma

Answer

Medullary carcinoma

Answer

Follicular carcinoma

Answer

Anaplastic carcinoma

Question 9

Which of the following complications will NOT lead to respiratory distress after thyroid surgery?

Accepted Answer

Hypocalcemia

Answer

Seroma at the surgical site

Answer

Recurrent laryngeal nerve injury

Answer

Hematoma at the surgical site

Question 10

A 40-year-old female who underwent subtotal thyroidectomy developed respiratory distress 8 hours after the operation. The skin sutures were opened in the ward but the distress persisted. What is the next likely step in management?

Accepted Answer

Open the layers of the wound in the ward.

Answer

Immediately shift the patient to the operation theatre.

Answer

Patient should be intubated in the ward.

Answer

External pressure should be applied over the neck to stop bleeding.

Endocrine Surgery — MCQs

Endocrine Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?